Heartbeam Inc (BEAT)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Heartbeam Inc Stock (BEAT) Company Profile

Heartbeam Inc

Healthcare (1126)

408-899-4443

2118 WALSH AVE., SUITE 210, SANTA CLARA

Prossima data di guadagno

Ultimi documenti SEC

BEAT's Discussions on Twitter

Confronta BEAT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BEAT Heartbeam Inc	2.56	79.22M	0	-20.34M	-15.59M	-0.697
VEEV Veeva Systems Inc	219.78	36.70B	3.08B	860.33M	1.35B	5.1463
TEM Tempus Ai Inc	69.38	12.56B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	45.00	8.26B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	96.05	8.27B	1.15B	96.70M	-161.99M	1.09
BTSG Brightspring Health Services Inc	36.48	6.59B	11.99B	24.18M	234.31M	0.2956

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-11	Aggiornamento	The Benchmark Company	Speculative Buy → Buy
2025-12-08	Iniziato	H.C. Wainwright	Buy
2025-10-31	Iniziato	Roth Capital	Buy
2020-09-11	Iniziato	Needham	Buy
2020-09-02	Iniziato	Robert W. Baird	Neutral
2020-01-08	Iniziato	SunTrust	Buy
2019-08-02	Downgrade	Raymond James	Outperform → Mkt Perform
2019-04-26	Reiterato	Dougherty & Company	Buy
2018-07-26	Reiterato	Lake Street	Buy
2018-04-26	Reiterato	The Benchmark Company	Buy
2018-02-23	Reiterato	Dougherty & Company	Buy
2017-11-08	Reiterato	Dougherty & Company	Buy
2017-10-26	Iniziato	Raymond James	Outperform
2017-10-24	Iniziato	SunTrust	Buy
2017-08-09	Reiterato	Dougherty & Company	Buy
2017-07-19	Reiterato	The Benchmark Company	Buy
2017-04-11	Reiterato	Dougherty & Company	Buy
2016-12-02	Iniziato	Dougherty & Company	Buy
2016-09-13	Iniziato	Sidoti	Buy
2016-08-03	Reiterato	The Benchmark Company	Buy
2015-07-28	Reiterato	Dougherty & Company	Buy
2013-10-24	Iniziato	The Benchmark Company	Buy
2013-08-21	Iniziato	Dougherty & Company	Buy

Mostra tutto

Heartbeam Inc Borsa (BEAT) Ultime notizie

Heartbeam Inc Azioni (BEAT) Dati Finanziari

Heartbeam Inc (BEAT)

Heartbeam Inc Stock (BEAT) Company Profile

Confronta BEAT con altri titoli

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

Heartbeam Inc Borsa (BEAT) Ultime notizie

HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN

HeartBeam Stock 7-Day Winning Spree: Stock Climbs 227% - Trefis

Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

HeartBeam Shares Skyrocket: FDA Boost - timothysykes.com

HeartBeam Soars with FDA Approval for Breakthrough ECG Technology - timothysykes.com

HeartBeam Stock Soars: Should You Buy? - timothysykes.com

Heartbeam stock is a buy, this analyst says - Cantech Letter

HeartBeam Stock Surges 201%, With A 6-Day Winning Spree - Trefis

Benchmark Upgrades HeartBeam (BEAT) - Nasdaq

BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System - sharewise.com

HeartBeam updates regulatory strategy for 12-lead ECG Synthesis Software - MSN

HeartBeam Stock Surges: Analyzing the Uptrend - StocksToTrade

Why Is Micro Cap HeartBeam Stock Surging On Wednesday? - Sahm

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

HeartBeam swells on turning FDA rejection into ECG clearance - Fierce Biotech

symbol__ Stock Quote Price and Forecast - CNN

3 Penny Stocks to Watch Now, 12/11/25 - TipRanks

Why did BEAT stock rocket 72% in pre-market today? - MSN

HeartBeam receives US FDA clearance for at-home arrhythmia assessment with cable-free 12-lead ECG - Cardiac Rhythm News

HeartBeam (BEAT) Receives Upgrade from Benchmark Analyst | BEAT Stock News - GuruFocus

HeartBeam go-to-market strategy remains on track, says Benchmark - TipRanks

HeartBeam stock soars as H.C. Wainwright doubles price target on FDA clearance - Investing.com India

HeartBeam sinks after ‘Not Substantially Equivalent’ letter from FDA - MSN

HeartBeam (BEAT) Stock Soars After FDA Clearance: Latest News, Forecasts and Analyst Views - ts2.tech

Most Active U.S. Stocks Today: HeartBeam, Nvidia, Tesla, Netflix and Nextdoor Lead Volatile Trade (Dec. 11, 2025) - ts2.tech

5-Day Rally Sends HeartBeam Stock Up 120% - Trefis

HeartBeam Receives FDA Clearance for 12-Lead ECG Synthesis Software Following Appeal - citybuzz

HeartBeam announces FDA clearance for 12-lead ECG synthesis software - MSN

Oracle, Synopsys, Heartbeam, Planet Labs And Adobe: Why These 5 Stocks Are On Investors' Radars Today - Benzinga

HC Wainwright & Co. Maintains HeartBeam (BEAT) Buy Recommendation - Nasdaq

Heartbeam wins appeal, gains FDA clearance - BioWorld MedTech

FDA Greenlight Sends HeartBeam, Photronics, And Designer Brands Shares Climbing - Finimize

HeartBeam (BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - Yahoo Finance

HeartBeam’s Leap: Should Investors Be Wary? - StocksToTrade

FDA Clears HeartBeam Cable-free 12-lead ECG - respiratory-therapy.com

HeartBeam Secures FDA Clearance for 12-Lead ECG Synthesis Software Following Appeal - citybuzz

HeartBeam (BEAT) Stock: Surges 50% After FDA Grants Clearance For its 12-lead ECG Device - parameter.io

HeartBeam (BEAT) Analyst Rating: HC Wainwright Raises Price Targ - GuruFocus

HeartBeam price target raised to $5.50 from $2.50 at H.C. Wainwright - TipRanks

FDA clears HeartBeam’s at-home arrhythmia assessment tool - Yahoo

Weekly Trades: Is HeartBeam Inc stock recession proofTrade Entry Report & Community Trade Idea Sharing Platform - BỘ NỘI VỤ

HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - TipRanks

HeartBeam Receives FDA Clearance for 12-Lead ECG for At-Home Arrhythmia Assessment - marketscreener.com

HeartBeam Wins FDA Nod for Cable-Free 12-Lead ECG for Home Arrhythmia Assessment - Medical Product Outsourcing

HeartBeam Shares Surge: Buy Signal? - timothysykes.com

HeartBeam : Earnings Documents - marketscreener.com

HeartBeam stock soars after FDA clearance for 12-lead ECG synthesis software - Investing.com Nigeria

Why Is HeartBeam Stock (BEAT) Up Today? - TipRanks

Heartbeam rises after FDA clears its cable‑free ECG software - TradingView — Track All Markets

HeartBeam’s 12-lead ECG synthesis software receives FDA clearance By Investing.com - Investing.com Australia

HeartBeam’s 12-lead ECG synthesis software receives FDA clearance - Investing.com India

Heartbeam Inc Azioni (BEAT) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a BEAT